Rare variant association data from human genetics combined with in vitro and in vivo functional validation highlight ANGPTL7 as a promising therapeutic target for intraocular pressure reduction, and protection from glaucoma.
- Kavita Praveen
- Gaurang C. Patel
- Giovanni Coppola